JA Solar to Host First Quarter 2017 Results Conference Call on May 24, 2017
May 11, 2017 10:32 am UTC| Business
BEIJING, May 11, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or "JA"), one of the world's largest manufacturers of high-performance solar power products, today announced that it will report its...
JA Solar to Host First Quarter 2017 Results Conference Call on May 24, 2017
May 11, 2017 10:32 am UTC| Business
BEIJING, May 11, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or "JA"), one of the world's largest manufacturers of high-performance solar power products, today announced that it will report its...
JA Solar to Host First Quarter 2017 Results Conference Call on May 24, 2017
May 11, 2017 10:32 am UTC| Business
BEIJING, May 11, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or "JA"), one of the world's largest manufacturers of high-performance solar power products, today announced that it will report its...
Histogenics Corporation Announces First Quarter 2017 Financial and Operating Results
May 11, 2017 10:31 am UTC| Business
‒ NeoCart® Phase 3 Clinical Trial Enrollment Near Completion ‒‒ NeoCart Approval Pathway in Japan Defined After Successful Conclusion of Discussions with the Japan Pharmaceuticals and Medical Devices Agency ‒‒ Publication...
Histogenics Corporation Announces First Quarter 2017 Financial and Operating Results
May 11, 2017 10:31 am UTC| Business
‒ NeoCart® Phase 3 Clinical Trial Enrollment Near Completion ‒‒ NeoCart Approval Pathway in Japan Defined After Successful Conclusion of Discussions with the Japan Pharmaceuticals and Medical Devices Agency ‒‒ Publication...
Histogenics Corporation Announces First Quarter 2017 Financial and Operating Results
May 11, 2017 10:32 am UTC| Business
‒ NeoCart® Phase 3 Clinical Trial Enrollment Near Completion ‒‒ NeoCart Approval Pathway in Japan Defined After Successful Conclusion of Discussions with the Japan Pharmaceuticals and Medical Devices Agency ‒‒ Publication...
Auris Medical Provides Business Update and Reports First Quarter 2017 Financial Results
May 11, 2017 10:16 am UTC| Business
Progressing toward completed enrollment of the AM-111 Phase 3 HEALOS trial Key Opinion Leader event scheduled for June 16 in New York City Conference call set for 8 am ET (2 pm CET) today Zug, Switzerland, May...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight